Cite
HARVARD Citation
Cutter, G. et al. (2014). Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?. Multiple sclerosis. pp. 1304-1305. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cutter, G. et al. (2014). Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?. Multiple sclerosis. pp. 1304-1305. [Online].